Berapa harga RegeneRx Biopharmaceuticals, Inc. (RGRX)

Harga RegeneRx Biopharmaceuticals, Inc. (RGRX) adalah $0.0007

Apa kapitalisasi pasar RegeneRx Biopharmaceuticals, Inc. (RGRX)

Kapitalisasi pasar RegeneRx Biopharmaceuticals, Inc. (RGRX) adalah $1.05K

RegeneRx Biopharmaceuticals, Inc. (RGRX) Imbal Hasil Dividen

RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and regeneration of tissues and organs. The company's development pipeline includes RGN-259, a preservative-free ophthalmic solution designed to restore corneal tissues following injury, disease, or other pathologies; RGN-352, an injectable formulation under investigation for its potential in treating cardiovascular ailments, central and peripheral nervous system disorders, and various other medical conditions; and RGN-137, a topical gel aimed at accelerating the healing of skin wounds and minimizing scar tissue. Strategic alliances have been forged with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. Incorporated in 1982, the company initially operated as Alpha 1 Biomedicals, Inc., adopting the name RegeneRx Biopharmaceuticals, Inc. in 2000. Its operations are headquartered in Rockville, Maryland.

Tahun	Hasil Dividen	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Hasil Dividen

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Perusahaan	Hasil Dividen	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Lonza Group AG LONN.SW	0.00%	CH
UCB S.A. UCB.BR	0.65%	BE
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	KR

Perusahaan

Hasil Dividen

Negara